Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

Clinical trial NCT00442871 · COMPLETED

Trial details

NCT number: NCT00442871
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2006-09-28
Primary completion: 2008-01-03
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.